ACP3 and prostate cancer: In vivo study with male Wistar rats subacute orally treated with mercury chloride demonstrated increased activity of total acid phosphatase, prostatic acid phosphatase, and prostatic alkaline phosphatase as early markers of prostate cancer, in comparison to nonexposed animals [76]; however, human studies have not yet found a distinct association.